BLFS vs MMSI
As of Sep 20, 2026, Biolife Solutions (BLFS) scores 5.8/10 and Merit Medical Systems (MMSI) 6.3/10 on AlphaStocks' five-model composite, so MMSI scores higher. MMSI trades 33% above its model fair value.
BLFS
BIOLIFE SOLUTIONS INC
5.8
Consider Buy
$36.67
MMSI
MERIT MEDICAL SYSTEMS INC
6.3
Consider Buy
$85.33
BLFS vs MMSI: Which is the Better Investment?
BIOLIFE SOLUTIONS INC (BLFS) scores 5.8/10 while MERIT MEDICAL SYSTEMS INC (MMSI) scores 6.3/10 on AlphaStocks' composite model. MERIT MEDICAL SYSTEMS INC has the higher composite rating of Consider Buy.
This comparison is algorithmically generated and is not financial advice.
| Metric | BLFS | MMSI |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 5.8/10 | 6.3/10▲ |
| Rating | Consider Buy | Consider Buy▲ |
| Price | $36.67 | $85.33 |
| P/E Ratio | — | 40.1 |
| ROE | -0.9% | 8.3%▲ |
| Market Cap | $2B | $5B |
| Fair Value | — | $64.30 |
| Dividend Yield | — | — |
| Sector Rank | #62 of 168 | #36 of 168▲ |
| Model Verdicts | ||
| Piotroski | Strong | Strong |
| Buffett | Caution | Attractive▲ |
| Graham | Neutral | Neutral |
| Lynch | Limited Data | Neutral▲ |
| Greenblatt | Caution | Neutral▲ |
Related comparisons
BLFS vs MMSI: Which Stock Scores Higher?
BIOLIFE SOLUTIONS INC (BLFS) and MERIT MEDICAL SYSTEMS INC (MMSI) are both in the Health Care sector. MMSI currently leads with a composite score of 6.3/10 (Consider Buy) compared to BLFS's 5.8/10 (Consider Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer